Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tocilizumab in moderate to severe active rheumatoid arthritis
NCT00531817Phase 3Completed
- Sponsor
- Roche
- Start
- Oct 2007
- Primary completion
- Jun 2009
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Engineered Antibody Formats
- Countries
- 2
01
Overview
A Phase 3 trial of tocilizumab in rheumatoid arthritis (RA), sponsored by Roche. Started Oct 2007; status: completed.
02
Drugs
tocilizumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00531817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00531817.